123 related articles for article (PubMed ID: 20233675)
21. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.
Chernesky M; Jang D; Smieja M; Portillo E; Ewert R; Pritchard C; MacEachern D; Doucette C; MacDonald A; Kapala J; Sumner J; Hill C
Sex Transm Dis; 2009 Sep; 36(9):581-3. PubMed ID: 19661842
[TBL] [Abstract][Full Text] [Related]
22. Reflex human papillomavirus DNA testing on residual liquid-based (TPPT) cervical samples: focus on age-stratified clinical performance.
Sarode VR; Werner C; Gander R; Foster B; Fulmer A; Saboorian MH; Ashfaq R
Cancer; 2003 Jun; 99(3):149-55. PubMed ID: 12811855
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
[TBL] [Abstract][Full Text] [Related]
24. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
25. Detection and genotyping analysis of human papillomavirus isolates from liquid-based cervical cytology specimens.
Avissar P; Malinowski DP
Methods Mol Biol; 2009; 511():361-70. PubMed ID: 19347306
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus detection: verification with cervical cytology.
Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of accuracy of three assays for human papillomavirus detection and typing: Hybrid Capture 2, HPV Consensus kit and Amplicor HPV].
Hantz S; Caly H; Decroisette E; Dutrop A; Bakeland D; Pascal B; Darreye G; Dussartre C; Renaudie J; Rogez S; Aubard Y; Denis F; Alain S
Pathol Biol (Paris); 2008 Feb; 56(1):29-35. PubMed ID: 18178026
[TBL] [Abstract][Full Text] [Related]
28. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
29. The effect of different DNA isolation methods on the outcome of high-risk HPV testing.
Oevestad IT; Janssen EA; Baak JP
Indian J Pathol Microbiol; 2007 Oct; 50(4):733-9. PubMed ID: 18306539
[TBL] [Abstract][Full Text] [Related]
30. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
Levi AW; Bernstein JI; Hui P; Duch K; Schofield K; Chhieng DC
Arch Pathol Lab Med; 2016 Feb; 140(2):153-7. PubMed ID: 26910220
[TBL] [Abstract][Full Text] [Related]
31. Stability of PreservCyt for Hybrid Capture (HC II) HPV test.
Sailors J; Gander R; Saboorian MH; Berkley P; Foster B; Ashfaq R
Diagn Cytopathol; 2005 May; 32(5):260-3. PubMed ID: 15830373
[TBL] [Abstract][Full Text] [Related]
32. Hybrid capture as a means of detecting human papillomavirus DNA from liquid-based cytology specimens: a preliminary evaluation.
Callaghan J; Karim S; Mortlock S; Wintert M; Woodward N
Br J Biomed Sci; 2001; 58(3):184-9. PubMed ID: 11575742
[TBL] [Abstract][Full Text] [Related]
33. Potential applications of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa.
Kujan O; Desai M; Sargent A; Bailey A; Turner A; Sloan P
Oral Oncol; 2006 Sep; 42(8):810-8. PubMed ID: 16458571
[TBL] [Abstract][Full Text] [Related]
34. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
35. Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland.
Dobec M; Bannwart F; Kaeppeli F; Cassinotti P
J Clin Virol; 2009 May; 45(1):23-7. PubMed ID: 19375383
[TBL] [Abstract][Full Text] [Related]
36. Development of optimal liquid based cytology sample processing methods for HPV testing: minimising the 'inadequate' test result.
Peevor R; Jones J; Fiander AN; Hibbitts S
J Virol Methods; 2011 May; 173(2):374-7. PubMed ID: 21295606
[TBL] [Abstract][Full Text] [Related]
37. Recovery of human papillomavirus nucleic acids from liquid-based cytology media.
Powell N; Smith K; Fiander A
J Virol Methods; 2006 Oct; 137(1):58-62. PubMed ID: 16828171
[TBL] [Abstract][Full Text] [Related]
38. NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.
Jeantet D; Schwarzmann F; Tromp J; Melchers WJ; van der Wurff AA; Oosterlaken T; Jacobs M; Troesch A
J Clin Virol; 2009 Jul; 45 Suppl 1():S29-37. PubMed ID: 19651366
[TBL] [Abstract][Full Text] [Related]
39. Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology medium.
Cuschieri KS; Beattie G; Hassan S; Robertson K; Cubie H
J Virol Methods; 2005 Mar; 124(1-2):211-5. PubMed ID: 15664071
[TBL] [Abstract][Full Text] [Related]
40. Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media.
Agreda PM; Beitman GH; Gutierrez EC; Harris JM; Koch KR; LaViers WD; Leitch SV; Maus CE; McMillian RA; Nussbaumer WA; Palmer ML; Porter MJ; Richart GA; Schwab RJ; Vaughan LM
J Clin Microbiol; 2013 Aug; 51(8):2702-6. PubMed ID: 23678069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
